Search results
Results from the WOW.Com Content Network
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents.It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. [1]
In regard to the potential benefit that drug-resistant cells can be recruited for effective therapy by combining chemotherapy with hyperthermia, it was important to show that chemoresistance against several anticancer drugs (e.g. mitomycin C, anthracyclines, BCNU, melphalan) including CDDP could be reversed at least partially by the addition of ...
The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers. [1] It is related to the journal Current Medicinal Chemistry and was established in 2001 as Current Medicinal Chemistry – Anti-Cancer Agents. [2]
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University ...
Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, including sarcomas, some carcinomas (e.g., small cell lung cancer, squamous cell carcinoma of the head and neck and ovarian cancer), lymphomas, bladder cancer, cervical cancer, [9] and germ cell tumors.
It publishes numerous journals, books, newsletters, and online and multimedia resources; it publishes the Journal of Clinical Oncology (JCO), [2] the JCO Oncology Practice (JCO OP), [3] and the JCO Global Oncology (JCO GO), [4] JCO Clinical Cancer Informatics, which publishes clinically relevant research based on biomedical informatics methods ...
Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies: Hypercholesterolaemia, cataract, urinary retention, hypocalcaemia, osteonecrosis of the jaw and anaphylaxis. Gemtuzumab ozogamicin: IV: CD33 antibody that induces apoptosis of the tagged cell. Acute myeloid leukaemia